Study of SARS-CoV-2 in semen from asymptomatic donors with the presence of virus in nasopharyngeal swabs

Reprod Biomed Online. 2023 Dec;47(6):103321. doi: 10.1016/j.rbmo.2023.103321. Epub 2023 Jul 30.

Abstract

Research question: Is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present in semen samples from asymptomatic donors who have positive virus results from nasopharyngeal swabs?

Design: Nasopharyngeal PCR was performed on 1943 sperm donors between January 2021 and March 2022. The result was positive for 140 donations, and the presence of SARS-CoV-2 could be studied in cryopreserved semen from 84 of these donors. This included 67 participants in whom the quality of fresh semen could be compared with the previous donation, the day of the PCR-positive nasopharyngeal sampling and the first subsequent donation. Semen donations were cryopreserved following total semen (n = 26) or ready-to-use (n = 58) protocols. The presence of SARS-CoV-2 in cryopreserved samples was determined by reverse transcription PCR. Semen quality (volume, concentration and progressive motility) was evaluated in accordance with World Health Organization 2010 recommendations.

Results: SARS-CoV-2 virus was not detected in any cryopreserved total semen or ready-to-use samples. No significant differences in semen volume, concentration or progressive motility were observed between the last previous donation, the day of the positive PCR nasopharyngeal sampling and the first subsequent donation.

Conclusions: The lack of detection of SARS-CoV-2 in semen samples from asymptomatic individuals infected with SARS-CoV-2 supports the safety of assisted human reproduction treatments using this type of sample.

Keywords: Asymptomatic donors; PCR; SARS-CoV-2; Semen; Vaccination.

MeSH terms

  • COVID-19* / diagnosis
  • Humans
  • Male
  • Nasopharynx
  • RNA, Viral
  • SARS-CoV-2*
  • Semen
  • Semen Analysis

Substances

  • RNA, Viral